Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ryan P. Larson"'
Autor:
Robert Stewart, Brieanna Watters, Veronica Horowitz, Ryan P. Larson, Brian Sargent, Christopher Uggen
Publikováno v:
RSF: The Russell Sage Foundation Journal of the Social Sciences, Vol 8, Iss 2, Pp 137-156 (2022)
Native Americans are disproportionately affected by the criminal legal system, yet comparative analyses of criminal legal outcomes and experiences among racial and ethnic groups rarely center the experiences of Native Americans. This multimethod stud
Externí odkaz:
https://doaj.org/article/681e4c8aa84640b4aaed571b2d3cc5e2
Autor:
Byoung Y Ryu, Kathryn R Michels, Alyssa Sheih, Susana A Hernandez, Alissa H Brandes, Don Parrilla, Blythe Irwin, Anai M Perez, Hung-An Ting, Christopher J Nicolai, Timothy Gervascio, Seungjin Shin, Mark D Pankau, Mason Muhonen, Jessica Freeman, Sarah Gould, Rich Getto, Ryan P Larson, Andrew M Scharenberg, Alessandra M Sullivan, Shon Green
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background Chimeric antigen receptor (CAR) T-cell therapies have demonstrated transformational outcomes in the treatment of B-cell malignancies, but their widespread use is hindered by technical and logistical challenges associated with ex vivo cell
Externí odkaz:
https://doaj.org/article/a89752227f79448587a521f6cc52e072
Autor:
Denis Escobar, Osman Archaga, Allan Reyes, Adalid Palma, Ryan T. Larson, Gissella M. Vásquez, Gustavo Fontecha
Publikováno v:
Insects, Vol 13, Iss 6, p 548 (2022)
Anopheles species are the vectors of malaria, one of the diseases with the greatest impact on the health of the inhabitants of the tropics. Due to their epidemiological relevance and biological complexity, monitoring of anopheline populations in curr
Externí odkaz:
https://doaj.org/article/c57bfd31d64b447dbfc485acad6ef046
Autor:
Kathryn R Michels, Alyssa Sheih, Susana A Hernandez, Alissa H Brandes, Don Parrilla, Blythe Irwin, Anai M Perez, Hung-An Ting, Christopher J Nicolai, Timothy Gervascio, Seungjin Shin, Mark D Pankau, Mason Muhonen, Jessica Freeman, Sarah Gould, Rich Getto, Ryan P Larson, Byoung Y Ryu, Andrew M Scharenberg, Alessandra M Sullivan, Shon Green
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006292
BackgroundChimeric antigen receptor (CAR) T-cell therapies have demonstrated transformational outcomes in the treatment of B-cell malignancies, but their widespread use is hindered by technical and logistical challenges associated with ex vivo cell m
Autor:
Shahin Shafiani, Pamela J. Fink, Albanus O. Moguche, C.J. Cambier, Lauren E. Higdon, Corey Clemons, Alena M. Gallegos, James R. Sissons, Kevin B. Urdahl, Ryan P. Larson, Crystal Dinh
Publikováno v:
The Journal of Experimental Medicine
Protective CD4 T cells specific for M. tuberculosis (Mtb) are maintained in the lungs during active Mtb infection. Similar to memory CD4 T cells, persistence of these Mtb-specific cells requires intrinsic expression of Bcl6 and ICOS.
Immune cont
Immune cont
Autor:
Albanus O. Moguche, David R. Sherman, Peter Bang, Peter Andersen, Virginie Rozot, Shahin Shafiani, Adam Penn-Nicholson, Thomas J. Scriba, Hennie Geldenhuys, Denise M. McKinney, Deborah Abrahams, Kevin B. Urdahl, Søren T. Hoff, Shuyi Ma, Mark Hatherill, Holden T. Maecker, Willem A. Hanekom, Cecilia S. Lindestam Arlehamn, One B. Dintwe, Munyaradzi Musvosvi, Alessandro Sette, Ingrid Kromann, Courtney R. Plumlee, Helen Mearns, Morten Ruhwald, Ryan P. Larson, Erica Smit
CD4 T cells are critical for protective immunity against Mycobacterium tuberculosis (Mtb), the cause of tuberculosis (TB). Yet, to-date, TB vaccine candidates that boost antigen-specific CD4 T cells have conferred little or no protection. Here we exa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9b31990a1b02fb62b529e96f8b7dd34
https://europepmc.org/articles/PMC5533182/
https://europepmc.org/articles/PMC5533182/
Autor:
Afshin Mashadi-Hossein, Jeffrey Teoh, Ryan P Larson, Rachel K Yost, Ronald J. Hause, Yue Jiang
Publikováno v:
Blood. 134:591-591
Introduction: Liso-cel is an investigational, anti-CD19, defined composition (4-1BB) chimeric antigen receptor (CAR) T cell product administered at a target dose of CD4+ and CD8+ CAR T cells. Liso-cel manufacturing process design includes controls th
Autor:
Rachel K Yost, Brian Christin, Ronald J. Hause, Christopher Glen Ramsborg, Ryan P Larson, Heidi H. Gillenwater, Tina Albertson, Lauren F. Brown, Jeffrey Teoh, Paul Guptill, Timothy G. Johnstone, Mary Mallaney, Aditya Radhakrishnan, Neil A. Haig
Publikováno v:
Blood. 134:593-593
Background Lisocabtagene maraleucel (liso-cel) is an investigational, CD19-directed, genetically modified, autologous cellular immunotherapy administered as a defined composition of CD8+ and CD4+ components to deliver target doses of viable chimeric
Autor:
Christine L. Cosma, Kevin K. Takaki, Ryan P. Larson, Lalita Ramakrishnan, David M. Tobin, Kevin B. Urdahl, C.J. Cambier, Rafael E Hernandez
Publikováno v:
Nature
The evolutionary survival of Mycobacterium tuberculosis, the cause of human tuberculosis, depends on its ability to invade the host, replicate, and transmit infection. At its initial peripheral infection site in the distal lung airways, M. tuberculos